BLCO vs RXST: stock comparison and AI forecast
Bausch & Lomb Corp (BLCO) and Rxsight, Inc. (RXST) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
BLCO Bausch & Lomb Corp
- Price
- $19.99 +25.6% · 6M
- Market Cap
- $7.15B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
RXST Rxsight, Inc.
- Price
- $4.54 -21.7% · 6M
- Market Cap
- $189M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- BLCO is 37.8 times larger than RXST by market capitalization ($7.15B against $189M).
- Over the last six months BLCO returned +25.6% and RXST -21.7%.
- BLCO carries 1.16 times debt per unit of equity, against 0.34 times for RXST.
- Both companies share the SEC industry classification Ophthalmic Goods.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | BLCO | RXST |
|---|---|---|
| Market Cap | $7.15B | $189M |
| P/B Ratio | 1.11x | 0.74x |
| EPS | $-0.85 | $-1.10 |
| Book Value/Share | $18.01 | $6.13 |
| Revenue/Share | $15.16 | $2.93 |
| FCF/Share | $0.70 | $0.45 |
Profitability & Margins
| Metric | BLCO | RXST |
|---|---|---|
| ROE | – | -20.9% |
| ROA | – | -15.7% |
| ROIC | 3.2% | -23.1% |
| Gross Margin | – | 76.1% |
| Operating Margin | 7.1% | -50.4% |
| Net Margin | – | -43.8% |
| EBT Margin | -0.1% | -43.7% |
| Tax Rate | -2475.0% | -0.2% |
Financial Health
| Metric | BLCO | RXST |
|---|---|---|
| Current Ratio | 1.56x | 4.20x |
| Quick Ratio | 1.04x | 3.67x |
| D/E Ratio | 1.16x | 0.34x |
| Financial Leverage | 2.17x | 1.34x |
| Interest Coverage | 1.6x | -6172.7x |
| Working Capital | $1.09B | $240M |
Cash Flow
| Metric | BLCO | RXST |
|---|---|---|
| Operating Cash Flow | $554M | $24M |
| Free Cash Flow | $252M | $19M |
| Capital Spending | -$302M | -$5M |
| OCF Growth YoY | 227.8% | – |
| FCF/Sales | 4.7% | 15.3% |
| CapEx/Sales | 5.6% | 4.1% |
Operational Efficiency
| Metric | BLCO | RXST |
|---|---|---|
| Asset Turnover | 0.39x | 0.36x |
| Receivables Turnover | 4.7x | 7.2x |
| Inventory Turnover | – | 0.7x |
| Fixed Assets Turnover | 3.0x | 8.3x |
| Days Sales Outstanding | 77 days | 51 days |
| Days Inventory | – | 497 days |
| Payables Period | – | 43 days |
| Cash Conversion Cycle | – | 505 days |
Income Statement
| Metric | BLCO | RXST |
|---|---|---|
| Total Revenue | $5.42B | $122M |
| Operating Income | $383M | -$61M |
| Net Income | – | -$53M |
| R&D Expense | $400M | $37M |
| SG&A Expense | $2.25B | $117M |
| Cost of Goods Sold | – | $29M |
Dividend & Shareholder Information
| Metric | BLCO | RXST |
|---|---|---|
| Shares Outstanding | 358M | 42M |
BLCO vs RXST: stock comparison and AI forecast
Which is bigger, BLCO or RXST?
BLCO is 37.8 times larger than RXST by market capitalization ($7.15B against $189M).
Which stock performed better over the last six months, BLCO or RXST?
Over the last six months BLCO returned +25.6% and RXST -21.7%.
Which one does Intratio's AI model rank higher, BLCO or RXST?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.